Access the full text.
Sign up today, get DeepDyve free for 14 days.
(National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Acute myeloid leukemia version 2.2014. 2014.)
National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Acute myeloid leukemia version 2.2014. 2014.National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Acute myeloid leukemia version 2.2014. 2014., National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Acute myeloid leukemia version 2.2014. 2014.
Alexander Sherman, Gabriela Motyckova, K. Fega, D. DeAngelo, G. Abel, D. Steensma, M. Wadleigh, R. Stone, Jane Driver, Jane Driver, Jane Driver (2013)
Geriatric assessment in older patients with acute myeloid leukemia: a retrospective study of associated treatment and outcomes.Leukemia research, 37 9
F. Efficace, A. Novik, M. Vignetti, F. Mandelli, C. Cleeland (2007)
Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here?Haematologica, 92
U. Research, U. Health (2006)
Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidanceHealth and Quality of Life Outcomes, 4
H. Klepin, S. Danhauer, J. Tooze, Kylie Stott, K. Daley, T. Vishnevsky, B. Powell, S. Mihalko (2011)
Exercise for older adult inpatients with acute myelogenous leukemia: A pilot study.Journal of geriatric oncology, 2 1
S. Alibhai, M. Leach, M. Kowgier, G. Tomlinson, G. Tomlinson, J. Brandwein, M. Minden (2007)
Fatigue in older adults with acute myeloid leukemia: predictors and associations with quality of life and functional statusLeukemia, 21
T. Møller, L. Adamsen, C. Appel, Pernille Welinder, M. Stage, M. Jarden, Maiken Hjerming, L. Kjeldsen (2012)
Health related quality of life and impact of infectious comorbidity in outpatient management of patients with acute leukemiaLeukemia & Lymphoma, 53
J. Radich, M. Deininger, C. Abboud, J. Altman, E. Berman, R. Bhatia, B. Bhatnagar, P. Curtin, D. DeAngelo, J. Gotlib, G. Hobbs, M. Jagasia, H. Kantarjian, L. Maness, L. Metheny, J. Moore, A. Pallera, Philip Pancari, M. Patnaik, E. Purev, M. Rose, N. Shah, B. Smith, D. Snyder, K. Sweet, M. Talpaz, James Thompson, David Yang, K. Gregory, Hema Sundar (2018)
Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology.Journal of the National Comprehensive Cancer Network : JNCCN, 16 9
A. Schumacher, D. Wewers, A. Heinecke, C. Sauerland, O. Koch, J. Loo, T. Büchner, W. Berdel (2002)
Fatigue as an important aspect of quality of life in patients with acute myeloid leukemia.Leukemia research, 26 4
A. Liberati, Douglas Altman, J. Tetzlaff, C. Mulrow, P. Gøtzsche, John Ioannidis, Mike Clarke, P. Devereaux, Jos Kleijnen (2009)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions : Explanation and Elaboration
(U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79.)
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79.U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79., U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79.
(2020)
[Adult].Gaceta medica de Mexico, 152 Suppl 1
M. Sekeres, R. Stone, D. Zahrieh, D. Neuberg, V. Morrison, D. Angelo, I. Galinsky, Stephanie Lee (2004)
Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndromeLeukemia, 18
P. Allart-Vorelli, Bertrand Porro, F. Baguet, A. Michel, Florence Cousson-Gélie (2015)
Haematological cancer and quality of life: a systematic literature reviewBlood Cancer Journal, 5
E. Oliva, F. Nobile, G. Alimena, F. Ronco, G. Specchia, S. Impera, M. Breccia, I. Vincelli, I. Carmosino, P. Guglielmo, D. Pastore, C. Alati, R. Latagliata (2011)
Quality of life in elderly patients with acute myeloid leukemia: patients may be more accurate than physiciansHaematologica, 96
D. Moher, A. Liberati, J. Tetzlaff, D. Altman (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA StatementOpen Medicine, 3
M. Calvert, M. Brundage, P. Jacobsen, H. Schünemann, F. Efficace (2013)
The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practiceHealth and Quality of Life Outcomes, 11
E. Kent, A. Ambs, S. Mitchell, S. Clauser, Ashley Smith, R. Hays (2015)
Health‐related quality of life in older adult survivors of selected cancers: Data from the SEER‐MHOS linkageCancer, 121
Julian Higgins, Sally Green (2010)
Cochrane Handbook for Systematic Reviews of InterventionsInternational Coaching Psychology Review
D. Moher, A. Liberati, J. Tetzlaff, D. Altman (2010)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.International journal of surgery, 8 5
D. Messerer, J. Engel, J. Hasford, M. Schaich, G. Ehninger, C. Sauerland, T. Büchner, A. Schumacher, R. Krahl, D. Niederwieser, J. Krauter, A. Ganser, U. Creutzig, H. Döhner, R. Schlenk (2008)
Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemiaHaematologica, 93
J. López-Jiménez, Eva Martín-Ballesteros, Anna Sureda, Carla Uralburu, Ignacio Lorenzo, R. CAMPO, Cristina Fernández, M. Calbacho, D. García-Belmonte, Gonzalo Fernández (2006)
Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: results of a multicenter, observational study.Haematologica, 91 1
A. Leunis, W. Redekop, C. Groot, B. Löwenberg (2014)
Impaired health‐related quality of life in acute myeloid leukemia survivors: a single‐center studyEuropean Journal of Haematology, 93
J. Bower, P. Ganz, Katherine Desmond, C. Bernaards, J. Rowland, B. Meyerowitz, T. Belin (2006)
Fatigue in long‐term breast carcinoma survivorsCancer, 106
K. Schultz, Lu Chen, Zhengjia Chen, T. Kawashima, K. Oeffinger, W. Woods, H. Nicholson, J. Neglia (2014)
Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: A report from the children's oncology groupPediatric Blood & Cancer, 61
F Baker, M Denniston, T Smith, MM West (2005)
Adult cancer survivors: how are they faring?Cancer, 104
A. Kornblith, J. Herndon, R. Weiss, Chunfeng Zhang, E. Zuckerman, Sylvia Rosenberg, M. Mertz, D. Payne, Mary Massie, J. Holland, Patti Wingate, L. Norton, J. Holland (2003)
Long‐term adjustment of survivors of early‐stage breast carcinoma, 20 years after adjuvant chemotherapyCancer, 98
Stefan Bieri, E. Roosnek, C. Helg, F. Verholen, D. Robert, B. Chapuis, Jakob Passweg, R. Miralbell, Y. Chalandon (2008)
Quality of life and social integration after allogeneic hematopoietic SCTBone Marrow Transplantation, 42
I. Jóhannsdóttir, M. Hjermstad, T. Moum, F. Wesenberg, L. Hjorth, H. Schrøder, Susanna Mört, G. Jonmundsson, Jon Loge (2012)
Increased prevalence of chronic fatigue among survivors of childhood cancers: A population‐based studyPediatric Blood & Cancer, 58
L. Slováček, B. Slováková, L. Jebavý (2006)
[Health and psychosocial aspects of quality of life in patients undergoing autologous progenitor stem cell transplantation].Casopis lekaru ceskych, 145 12
A Montazeri (2009)
Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008Health Qual Life Outcomes, 7
(Surveillance Epidemiology and End Results (SEER). SEER Stat Fact Sheets: Acute Myeloid Leukemia (AML). 2015.)
Surveillance Epidemiology and End Results (SEER). SEER Stat Fact Sheets: Acute Myeloid Leukemia (AML). 2015.Surveillance Epidemiology and End Results (SEER). SEER Stat Fact Sheets: Acute Myeloid Leukemia (AML). 2015., Surveillance Epidemiology and End Results (SEER). SEER Stat Fact Sheets: Acute Myeloid Leukemia (AML). 2015.
Laura Levit, E. Balogh, S. Nass, P. Ganz (2014)
Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis
A. Mehnert, U. Koch (2008)
Psychological comorbidity and health-related quality of life and its association with awareness, utilization, and need for psychosocial support in a cancer register-based sample of long-term breast cancer survivors.Journal of psychosomatic research, 64 4
Melissa Hudson (2005)
Cancer survivorship: resilience across the lifespan. Proceedings of the National Cancer Institute's and American Cancer Society's 2002 Cancer Survivorship Conference. June 2-4, 2002. Washington, DC, USA.Cancer, 104 11 Suppl
M. Jacobs, R. Macefield, J. Blazeby, I. Korfage, M. Henegouwen, H. Haes, E. Smets, M. Sprangers (2013)
Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancerQuality of Life Research, 22
F. Efficace, G. Kemmler, M. Vignetti, F. Mandelli, S. Molica, B. Holzner (2008)
Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - a systematic review to evaluate the added value in supporting clinical decision making.European journal of cancer, 44 11
M. Tallman, E. Wang, J. Altman, F. Appelbaum, V. Bhatt, D. Bixby, S. Coutre, M. Lima, A. Fathi, M. Fiorella, J. Foran, Aric Hall, Meagan Jacoby, J. Lancet, T. Leblanc, G. Mannis, G. Marcucci, Mike Martin, A. Mims, O. MargaretR., Donnell, R. Olin, D. Peker, A. Perl, D. Pollyea, K. Pratz, T. Prebet, F. Ravandi, P. Shami, R. Stone, S. Strickland, M. Wieduwilt, K. Gregory, Lydia Hammond, Ndiya Ogba (2019)
NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Acute Myeloid Leukemia, Version 3.2019
(2015)
SEER Stat Fact Sheets: Acute Myeloid Leukemia (AML)
A. Redaelli, J. Stephens, Suzanne Brandt, M. Botteman, C. Pashos (2004)
Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life.Cancer treatment reviews, 30 1
C. Battaglini, A. Hackney, Rey Garcia, D. Groff, E. Evans, T. Shea (2009)
The Effects of an Exercise Program in Leukemia PatientsIntegrative Cancer Therapies, 8
(2010)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
(The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011), 2011.)
The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011), 2011.The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011), 2011., The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011), 2011.
M. Watson, G. Buck, K. Wheatley, J. Homewood, A. Goldstone, J. Rees, A. Burnett (2004)
Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial.European journal of cancer, 40 7
M. Hofman, J. Ryan, C. Figueroa-Moseley, P. Jean-Pierre, G. Morrow (2007)
Cancer-related fatigue: the scale of the problem.The oncologist, 12 Suppl 1
L. Wagner, D. Cella (2004)
Fatigue and cancer: causes, prevalence and treatment approachesBritish Journal of Cancer, 91
R. Met, J. Reekers, M. Koelemay, D. Legemate, Rob Haan (2009)
Health and Quality of Life Outcomes
JE Bower, PA Ganz, KA Desmond, C Bernaards, JH Rowland, BE Meyerowitz (2006)
Fatigue in long-term breast carcinoma survivors: a longitudinal investigationCancer, 106
Oncol Ther (2017) 5:1–16 DOI 10.1007/s40487-016-0039-6 REVIEW Health-Related Quality of Life of Patients with Acute Myeloid Leukemia: A Systematic Literature Review . . . . Ellen E. Korol Sisi Wang Karissa Johnston Farhad Ravandi-Kashani Mark Levis Floortje van Nooten Received: October 31, 2016 / Published online: January 27, 2017 The Author(s) 2017. This article is published with open access at Springerlink.com was to identify and summarize estimates of ABSTRACT HRQoL in patients with AML, including patients with relapsed or refractory AML. Introduction: Patients with acute myeloid leu- Methods: A systematic literature review was kemia (AML), especially those with relapsed or performed. MEDLINE and EMBASE databases refractory AML, have poor clinical prognosis were searched for peer-reviewed literature pub- and outcomes. Health-related quality of life lished between 2004 and 2014 in the US and (HRQoL) assessments have become increasingly Europe. Abstracts from four relevant conference important in oncology, aiding in identifying proceedings between 2012 and 2014 were and informing supportive therapy needs during reviewed. Data from eligible studies were treatment and beyond; however, HRQoL in extracted describing the HRQoL instruments hematology, and AML in particular, has used, domains assessed, and HRQoL scores received relatively minor attention. The aim reported. Electronic supplementary
Oncology and Therapy – Springer Journals
Published: Jan 27, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.